G230153-NCT06216301

Dynamic List Information
Dynamic List Data
Study Title
LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Sponsor Name
NovoCure GmbH
NCT Number
NCT06216301
IDE Number
G230153
CMS Approval Date
2024-07-23
Category
B